|
1 |
Latest research and development trends in non-insulin anti-diabetics
Cheon, Hyae Gyeong;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.145-153,
|
|
2 |
Implications of microRNAs in the pathogenesis of diabetes
Park, Seung-Yoon;Jeong, Hyo-Jin;Yang, Won-Mo;Lee, Wan;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.154-166,
|
|
3 |
Genetics of type 2 diabetes and potential clinical implications
Kwak, Soo Heon;Park, Kyong Soo;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.167-177,
|
|
4 |
Causal effects of synthetic chemicals on mitochondrial deficits and diabetes pandemic
Park, Wook-Ha;Kang, Young-Chul;Piao, Ying;Pak, Daniel Hyungseok;Kim Pak, Youngmi;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.178-188,
|
|
5 |
Transcriptional regulators of hepatic gluconeogenesis
Oh, Kyoung-Jin;Han, Hye-Sook;Kim, Min-Jung;Koo, Seung-Hoi;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.189-200,
|
|
6 |
Molecular mechanisms of central leptin resistance in obesity
Jung, Chang Hee;Kim, Min-Seon;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.201-207,
|
|
7 |
Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 Diabetes
Lee, Jongsoon;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.208-222,
|
|
8 |
Role of autophagy in the progression from obesity to diabetes and in the control of energy balance
Quan, Wenying;Jung, Hye Seung;Lee, Myung-Shik;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.223-229,
|
|
9 |
Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy
Kume, Shinji;Kitada, Munehiro;Kanasaki, Keizo;Maegawa, Hiroshi;Koya, Daisuke;
/
The Pharmaceutical Society of Korea
, v.36, no.2, pp.230-236,
|
|